This study looks at exosomes, which are tiny carriers that help send important signals in the body. Researchers will take blood and tissue samples from patients with pancreatic cancer and compare them to samples from patients with noncancerous conditions. This will help create normal values since they currently do not exist. The goal is to see how exosome activity relates to outcomes and the chance of the cancer coming back. The findings will help in future studies.
The trial's ID number is NCT02393703. This is an observational study, meaning it is observing participants without giving them a specific treatment. The trial aims to include about 181 participants.
Who can join
Adults aged 18 and older can join if they are having specific surgeries for pancreatic conditions, including cancer or benign diseases. Patients receiving certain chemotherapy or radiation treatments recently may not be able to join. Healthy volunteers are welcome, and the trial team will confirm eligibility for everyone.
Conditions
Pancreatic Cancer, Benign Pancreatic Disease
Age group
Adult, Older adult
Sex
All sexes
The study team makes the final call on eligibility.
What happens in the study
Participants will provide blood and tissue samples. The main goal is to successfully isolate exosomes from these samples over the course of a year. Everyone will be involved in the same study activities without being divided into different treatment groups.
Where
This trial is enrolling at 1 location. Recruiting sites are listed first.
Treats pancreatic cancer, lung cancer and colorectal cancer. The main cancer doctor for adults. Manages your treatment and your care team. Recognized at state, national or international level.
Led global trials in liver and bile duct cancer. Treats pancreatic cancer, gallbladder cancer, bile duct cancer and liver cancer. Offers targeted therapy.
Directs genitourinary oncology at Huntsman Cancer Institute. Treats pancreatic cancer, liver cancer, gallbladder cancer and esophageal cancer. Also treats stomach cancer and colorectal cancer.